Cite
Thalmensi J, Pliquet E, Liard C, et al. Anticancer DNA vaccine based on human telomerase reverse transcriptase generates a strong and specific T cell immune response. Oncoimmunology. 2015;5(3):e1083670doi: 10.1080/2162402X.2015.1083670.
Thalmensi, J., Pliquet, E., Liard, C., Escande, M., Bestetti, T., Julithe, M., Kostrzak, A., Pailhes-Jimenez, A. S., Bourges, E., Loustau, M., Caumartin, J., Lachgar, A., Huet, T., Wain-Hobson, S., & Langlade-Demoyen, P. (2016). Anticancer DNA vaccine based on human telomerase reverse transcriptase generates a strong and specific T cell immune response. Oncoimmunology, 5(3), e1083670. https://doi.org/10.1080/2162402X.2015.1083670
Thalmensi, Jessie, et al. "Anticancer DNA vaccine based on human telomerase reverse transcriptase generates a strong and specific T cell immune response." Oncoimmunology vol. 5,3 (2016): e1083670. doi: https://doi.org/10.1080/2162402X.2015.1083670
Thalmensi J, Pliquet E, Liard C, Escande M, Bestetti T, Julithe M, Kostrzak A, Pailhes-Jimenez AS, Bourges E, Loustau M, Caumartin J, Lachgar A, Huet T, Wain-Hobson S, Langlade-Demoyen P. Anticancer DNA vaccine based on human telomerase reverse transcriptase generates a strong and specific T cell immune response. Oncoimmunology. 2015 Nov 05;5(3):e1083670. doi: 10.1080/2162402X.2015.1083670. eCollection 2016 Mar. PMID: 27141336; PMCID: PMC4839321.
Copy
Download .nbib